Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 ФГБОУ «Ставропольский государственный медицинский университет», Российская Федерация, г. Ставрополь, 355017, ул. Мира, 310; 2 Независимый исследователь в области психофармакологии, Израиль, Азур 5801726, ул. Бен-Гурион 26/7
Список исп. литературыСкрыть список 1. Банщиков ВМ, Невзорова ТА. Психиатрия: Учебник. М.:Медицина, 1969. 2. Беккер РА, Быков ЮВ, Шкурат АО, Воронина АС. Препараты магния в психиатрии, наркологии, неврологии и общей медицине. Часть I (историческая). Acta Biomedica Scientifica. 2019; 4(3): 63–80. 3. Беккер РА, Быков ЮВ. Препараты лития в психиатрии, наркологии и неврологии (к 70-летию открытия Джона Кейда). Часть I. Историческая. Acta Biomedica Scientifica. 2019; 4 (1): 72–80. 4. Вотчал БЕ. Очерки клинической фармакологии // М.: Медицина. – 1965. 5. Машковский МД. Лекарственные средства. 15-е изд., т. 1, М., 1982. 6. Adámek B. Indication for the use of iodine-bromide salt water in Roznov pod Radhostĕm. Fysiatr Revmatol Vestn. 1974; 52 (3): 147–151. 7. Balme RH. Early medicinal use of bromides. J Roy Coll Physicians. 1976;10:205–208. 8. Ban TA. The role of serendipity in drug discovery. Dialogues Clin Neurosci. 2006;8(3):335-44. doi: 10.31887/DCNS.2006.8.3/tban. 9. Berger FM. The pharmacological properties of 2-methyl, 2-n propyl-l,3 propandiol dicarbamate (Miltown), a new interneural blocking agent. J Pharmacol Exp Ther. 1954;112:413-423. 10. Bhatara VS, Sharma JN, Gupta S, Gupta YK. Images in psychiatry. Rauwolfia serpentina: the first herbal antipsychotic. Am J Psychiatry. 1997; 154 (7): 894. doi: 10.1176/ajp.154.7.894. 11. Bonkowsky HL, Sinclair PR, Emery S, Sinclair JF. Seizure management in acute hepatic porphyria: risks of valproate and clonazepam. Neurology. 1980; 30 (6): 588–592. doi: 10.1212/wnl.30.6.588. 12. Canavese C, De Costanzi E, Stratta P, Sabbioni E. A role for bromine deficiency in sleep disturbances of long-term dialysis patients. Am J Kidney Dis. 2006; 48 (6): 1018–1019. doi: 10.1053/j.ajkd.2006.08.033. 13. Carrigan MA, Uryasev O, Frye CB, Eckman BL, Myers CR, Hurley TD, Benner SA. Hominids adapted to metabolize ethanol long before human-directed fermentation. Proc Natl Acad Sci USA. 2015; 112 (2): 458–463. doi: 10.1073/pnas.1404167111. 14. Cohen IM. The benzodiazepines. In: Ayd FJ, Blackwell B, eds. Discoveries in Biological Psychiatry. Philadelphia, Pa; Toronto, Canada: J.B. Lippincott Company; 1970:110–141. 15. Doblin RE, Christiansen M, Jerome L, Burge B. The Past and Future of Psychedelic Science: An Introduction to This Issue. J Psychoactive Drugs. 2019;51(2):93-97. doi: 10.1080/02791072.2019.1606472. 16. Encyclopedia Britannica. Vol 1. Anilin. Chicago, III London, UK; Toronto, Canada; Geneva, Switzerland; Sydney, Australia; Tokyo, Japan; Manila, the Philippines William Benton; 1969:950. 17. Ewing JA., Grant WJ. The bromide hazard. Southern Med J. 1965;58:148–152. 18. Freeman AM, 3rd, Westphal JR, Norris GT, Roggero BA, Webb PB, Freeman KL, et al. Efficacy of ondansetron in the treatment of generalized anxiety disorder. Depress Anxiety. 1997;5:140–1. 19. Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry. 2020;11:595584. doi: 10.3389/fpsyt.2020.595584. 20. García-Gutiérrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J. Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders. Biomolecules. 2020;10(11):1575. doi: 10.3390/biom10111575. 21. Goenka AH. Rustom Jal Vakil and the saga of Rauwolfia serpentina. J Med Biogr. 2007; 15 (4): 195–200. doi: 10.1258/j.jmb.2007.06-53. 22. Grabowski ML, Kosińska B, Knap JP. Solec Spa – worldwide unique properties of Polish health resort in the service of rural medicine. Ann Agric Environ Med. 2018; 25 (1): 46–49. doi: 10.5604/12321966.1228402. 23. Griebell G, Holmes A. 50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov. 2013; 12 (9): 667–687. 24. Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev. 2010;2010:Cd006815. 25. Jacobsen E. The early history of psychotherapeutic drugs. Psychopharmacology (Berl). 1986;89(2):138-44. doi: 10.1007/BF00310617. 26. Khodarahmi P, Rostami P, Rashidi A, Khodarahmi I. Anxiolytic effect of noscapine in mice. Pharmacol Rep. 2006;58(4):568-570. 27. Laios K, Lytsikas-Sarlis P, Manes K, Kontaxaki MI, Karamanou M, Androutsos G. Drugs for mental illnesses in ancient greek medicine. Psychiatriki. 2019; 30 (1): 58–65. doi: 10.22365/jpsych.2019.301.58. 28. Lambert C, Rees WC. Intravenous barbiturates in treatment of hysteria. British Medical Journal. 1944; 2(4358): 70–73. 29. Lehmann HE, Ban TA. Pharmacotherapy of Tension and Anxiety. Springfield, III: Charles C. Thomas Publisher; 1970:12–13. 30. Liebig J. Ueber die Verbindungen welche durch die Einwirkung des Chlors auf Alcohol, Aether, Olbildendes Gas urtd Essiggeist Entstehen. Liebigs Annalen der Pharmazie. 1832;1:182–230. 31. Liebreich MEP. Das Chloral hydrate, ein neues Hypnoticum und Anaestheticum, und dessen Anwendung in der Medizin. Eine Arzneimeittel-Untersuchung. Berlin, Germany: Müller; 1869 32. López-Muñoz F, Alamo C, García-García P. The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs. J Anxiety Disord. 2011;25(4):554-62. doi: 10.1016/j.janxdis. 2011.01.002. 33. Magner LN, Kim OJ. A history of medicine. CRC Press. 2017. 34. Martin DC, Plagenhoef M, Abraham J, Dennison RL, Aronstam RS. Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol. 1995;49(6):809-817. doi: 10.1016/0006-2952(94)00519-r. 35. Nemeroff CB. Anxiolytics: past, present, and future agents. J Clin Psychiatry. 2003;64 Suppl 3:3-6. 36. Nielsen FH. Ultratrace elements in nutrition. Annu Rev Nutr. 1984; 4: 21–41. doi: 10.1146/annurev.nu.04.070184.000321. 37. Novakova G, Bonev P, Duro M, Azevedo R, Couto C, Pinto E, Almeida A. Serum Iodine and Bromine in Chronic Hemodialysis Patients-An Observational Study in a Cohort of Portuguese Patients. Toxics. 2023; 11 (3): 247. doi: 10.3390/toxics11030247. 38. Robinson E. Psychopharmacology: From serendipitous discoveries to rationale design, but what next? Brain Neurosci Adv. 2018; 2: 2398212818812629. doi: 10.1177/2398212818812629 39. Ruiz P. Comprehensive textbook of psychiatry. Cambridge University Press. 2017. 40. Samorini G. The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A worldwide overview. Journal of Psychedelic Studies. 2019; 3 (2): 63–80. doi: 10.1556/2054.2019.008. 41. Shorter E. A history of psychiatry. From the era of the asylum to the age of Prozac. New York: J Wiley; 1997. 42. Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019;393:768–77. 43. Sneader W. Drug discovery: a history. John Wiley and Sons. 2005. doi:10.1002/0470015535 44. Somers K. Notes on Rauwolfia and ancient medical writings of India. Med Hist. 1958; 2 (2): 87–91. doi: 10.1017/s0025727300023498. 45. Sourkes TL. Early clinical neurochemistry of CNS-active drugs. Chloral hydrate. Mol Chem Neurophath. 1992;17:21–30. 46. Townend W, Mackway-Jones K. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Phenytoin or paraldehyde as the second drug for convulsions in children. Emerg Med J. 2002;19(1):50. doi: 10.1136/emj.19.1.50. 47. Turchi R, Jemmi G, Barani B. The curative action of Monticelli Term's water in upper respiratory tract diseases. Ateneo Parmense Acta Biomed. 1976; 42 (5): 635–642. 48. Vidaurre J, Gedela S, Yarosz S. Antiepileptic Drugs and Liver Disease. Pediatr Neurol. 2017; 77: 23–36. doi: 10.1016/j.pediatrneurol.2017.09.013. 49. Weissman BA, Raveh L. Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties. Toxicol Appl Pharmacol. 2008;232(2):351-358. doi: 10.1016/j.taap.2008.07.005. 50. Wick J. The history of benzodiazepines. Consult Pharm. 2013;28(9):538-548. doi: 10.4140/TCP.n.2013.538. 51. Yanagisawa I, Torii S. A bromine compound existing in blood. Tohoku J Exp Med. 2002; 196 (3): 111–121. doi: 10.1620/tjem.196.111. 52. Hoyer K. The Ferraro method of intravenous ether therapy of depression. Nord Med. 1952;47(3):89-90. 53. Funkenstein DH, Meade LW. An evaluation of intravenous ether as a treatment for psychiatric patients. Am J Psychiatry. 1953;109(9):650-6. doi: 10.1176/ajp.109.9.650. 54. Wang YT, Yang SY, Wu VC, Wu KD, Fang CC. Pseudohyperchloraemia due to bromvalerylurea abuse. Nephrol Dial Transplant. 2005;20(8):1767-8. doi: 10.1093/ndt/gfh945.